Literature DB >> 21377268

Type I collagen down-regulates E-cadherin expression by increasing PI3KCA in cancer cells.

Jung-Chien Cheng1, Peter C K Leung.   

Abstract

The extracellular matrix (ECM) has been shown to induce the epithelial-mesenchymal transition (EMT), which is characterized by the loss of E-cadherin. However, little is known about the mechanisms by which collagen I, the most abundant component of ECM, induces this process. Here, we show that E-cadherin was down-regulated in response to collagen I in SKOV3 ovarian cancer cells and PC3 prostate cancer cells. Furthermore, collagen I induced the up-regulation of PIK3CA, which in turn contributed to the collagen I-induced down-regulation of E-cadherin by up-regulating its transcriptional repressors, Snail and Slug. Our data demonstrate that PIK3CA is a mediator of collagen I-induced down-regulation of E-cadherin.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21377268     DOI: 10.1016/j.canlet.2011.02.008

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

1.  Structure and Function of a Prostate Cancer Dissemination-Permissive Extracellular Matrix.

Authors:  Marie-France Penet; Samata Kakkad; Arvind P Pathak; Balaji Krishnamachary; Yelena Mironchik; Venu Raman; Meiyappan Solaiyappan; Zaver M Bhujwalla
Journal:  Clin Cancer Res       Date:  2016-10-31       Impact factor: 12.531

Review 2.  The role of Snail in prostate cancer.

Authors:  Bethany N Smith; Valerie A Odero-Marah
Journal:  Cell Adh Migr       Date:  2012-09-01       Impact factor: 3.405

3.  Pancreatic stellate cells promote hapto-migration of cancer cells through collagen I-mediated signalling pathway.

Authors:  J Lu; S Zhou; M Siech; H Habisch; T Seufferlein; M G Bachem
Journal:  Br J Cancer       Date:  2013-11-07       Impact factor: 7.640

4.  GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer.

Authors:  Kendra Hodgkinson; Laura A Forrest; Nhung Vuong; Kenneth Garson; Bojana Djordjevic; Barbara C Vanderhyden
Journal:  Oncogene       Date:  2018-07-04       Impact factor: 9.867

Review 5.  Context-dependent EMT programs in cancer metastasis.

Authors:  Nicole M Aiello; Yibin Kang
Journal:  J Exp Med       Date:  2019-04-11       Impact factor: 14.307

Review 6.  Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology.

Authors:  Neel I Nissen; Morten Karsdal; Nicholas Willumsen
Journal:  J Exp Clin Cancer Res       Date:  2019-03-06

7.  A complex of novel protease inhibitor, ovostatin homolog, with its cognate proteases in immature mice uterine luminal fluid.

Authors:  Hsien-Lu Huang; Szu-Chin Li; Jin-Fong Wu
Journal:  Sci Rep       Date:  2019-03-21       Impact factor: 4.379

8.  Involvement of host stroma cells and tissue fibrosis in pancreatic tumor development in transgenic mice.

Authors:  Itai Spector; Yael Zilberstein; Adi Lavy; Arnon Nagler; Olga Genin; Mark Pines
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

9.  The Initiator Methionine tRNA Drives Secretion of Type II Collagen from Stromal Fibroblasts to Promote Tumor Growth and Angiogenesis.

Authors:  Cassie J Clarke; Tracy J Berg; Joanna Birch; Darren Ennis; Louise Mitchell; Catherine Cloix; Andrew Campbell; David Sumpton; Colin Nixon; Kirsteen Campbell; Victoria L Bridgeman; Peter B Vermeulen; Shane Foo; Eleftherios Kostaras; J Louise Jones; Linda Haywood; Ellie Pulleine; Huabing Yin; Douglas Strathdee; Owen Sansom; Karen Blyth; Iain McNeish; Sara Zanivan; Andrew R Reynolds; Jim C Norman
Journal:  Curr Biol       Date:  2016-03-03       Impact factor: 10.834

10.  Tumor⁻Stroma Cross-Talk in Human Pancreatic Ductal Adenocarcinoma: A Focus on the Effect of the Extracellular Matrix on Tumor Cell Phenotype and Invasive Potential.

Authors:  Patrizia Procacci; Claudia Moscheni; Patrizia Sartori; Michele Sommariva; Nicoletta Gagliano
Journal:  Cells       Date:  2018-10-05       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.